Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study

(1) Introduction: Cardiovascular disease is associated with high mortality, especially in older people. This study aimed to characterize the evolution of combined multimorbidity and polypharmacy patterns in older people with different cardiovascular disease profiles. (2) Material and methods: This l...

Full description

Bibliographic Details
Published in:	Geriatrics
Main Authors:	Noemí Villén, Albert Roso-Llorach, Carlos Gallego-Moll, Marc Danes-Castells, Sergio Fernández-Bertolin, Amelia Troncoso-Mariño, Monica Monteagudo, Ester Amado, Concepción Violán
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Subjects:	polypharmacy multimorbidity elderly cardiovascular disease chronic disease combined patterns
Online Access:	https://www.mdpi.com/2308-3417/7/6/141

Similar Items

Polypharmacy in multimorbid older adults: protocol for a systematic review
by: Caroline Sirois, et al.
Published: (2017-05-01)

COMMUNITY PHARMACIST-PHYSICIAN COLLABORATION IN MANAGING POLYPHARMACY AND MULTIMORBIDITY IN POLAND AND PORTUGAL
by: Filipe Prazeres
Published: (2024-04-01)

The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study
by: Elnaz Faramarzi, et al.
Published: (2023-06-01)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
by: Yong Zhao, et al.
Published: (2023-07-01)

The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics
by: M. V. Leonova
Published: (2021-10-01)

SREBPs as the potential target for solving the polypharmacy dilemma
by: Xue Wang, et al.
Published: (2024-01-01)

Chronic diseases spectrum and multimorbidity in elderly inpatients based on a 12-year epidemiological survey in China
by: Shan Gao, et al.
Published: (2024-02-01)

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
by: Monika Kozieł, et al.
Published: (2021-01-01)

Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
by: Siobhán McGettigan, et al.
Published: (2024-04-01)

Polypharmacy: definition, impact on outcomes, need for correction
by: S. Yu. Martsevich, et al.
Published: (2023-07-01)

Polypharmacy in the Management of Arterial Hypertension—Friend or Foe?
by: Camelia Cristina Diaconu, et al.
Published: (2021-11-01)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
by: Luise Adam, et al.
Published: (2023-09-01)

Prevalence of polypharmacy in the older adult population within primary care in Portugal: a nationwide cross-sectional study
by: Pedro Augusto Simões, et al.
Published: (2020-03-01)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
by: Juan Wang, et al.
Published: (2022-01-01)

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
by: Juan Wang, et al.
Published: (2022-05-01)

Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry
by: Agnieszka Kotalczyk, et al.
Published: (2022-04-01)

Medication adherence in Jordanian patients with multimorbidity: a cross-sectional mixed-methods study in outpatient clinics
by: Anas Abed, et al.
Published: (2025-07-01)

Polypharmacy as an ordered indicator of therapeutic complexity in a national cardiovascular prevention programme
by: Jacek Gonos, et al.
Published: (2026-04-01)

Predictors of falls and hospital admissions in people with cognitive impairment in day-care: role of multimorbidity, polypharmacy, and potentially inappropriate medication
by: Jennifer Scheel, et al.
Published: (2022-08-01)

Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China
by: Bowen Zhang, et al.
Published: (2024-05-01)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis
by: Tatsunori Hanai, et al.
Published: (2023-03-01)

Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy
by: Catalina Rojas-Solé, et al.
Published: (2024-12-01)

Association between polypharmacy and 2-year outcomes among Chinese older inpatients: a multi-center cohort study
by: Xiaomeng Liu, et al.
Published: (2024-09-01)

Patient-Centered Prescription Model to improve therapeutic adherence in patients with multimorbidity
by: Javier González-Bueno, et al.
Published: (2018-05-01)

A need to integrate pharmacological management for multimorbidity into dementia guidelines in Australia
by: Sanket Nagar, et al.
Published: (2024-07-01)

Polypharmacy in Hypertension Management: Clinical Challenges and Drug-Drug Interactions: A Narrative Review
by: Amer Kadhim, et al.
Published: (2026-03-01)

Prevalence and Determinants of Multimorbidity, Polypharmacy, and Potentially Inappropriate Medication Use in the Older Outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia
by: Akshaya Srikanth Bhagavathula, et al.
Published: (2021-08-01)

Evaluation of The Association of Medication Adherence With Polypharmacy and Multimorbidity in Patients With Coronary Artery Disease
by: Sercan Bulut, et al.
Published: (2020-12-01)

Clinic for Multimorbidity: An Innovative Approach to Integrate General Practice and Specialized Health Care Services
by: Cathrine Bell, et al.
Published: (2023-06-01)

Investigating pain-related medication use and contribution to polypharmacy in adults with intellectual disabilities: a systematic review
by: Christine Pacitti, et al.
Published: (2024-12-01)

Medication adherence and associated factors among patients with multimorbidity in Bangladesh: a cross-sectional study
by: Madhu Ritu Bhadra Medha, et al.
Published: (2026-06-01)

Protocol for the development and validation of a Polypharmacy Assessment Score
by: Jung Yin Tsang, et al.
Published: (2024-07-01)

Measurement of polydoctoring as a crucial component of fragmentation of care among patients with multimorbidity: Cross‐sectional study in Japan
by: Takayuki Ando, et al.
Published: (2023-11-01)

Development and validation of a Japanese version of the multimorbidity treatment burden questionnaire
by: Takuya Aoki, et al.
Published: (2025-07-01)

Assessment of The Use of Poly pharmacy in Geriatric Patients With Multimorbidity In Kirkuk, Iraq
by: Raaid Kemal Thenoon Syah Mansoor, et al.
Published: (2022-12-01)

Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes
by: Jacob Astorp, et al.
Published: (2020-09-01)

Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019
by: Anuradhaa Subramanian, et al.
Published: (2023-01-01)

Polypharmacy Management in Elderly Patients with Multimorbidity
by: Wanyu PAN, Chunhui ZHANG, Zhenxiang ZHANG, Jing CHEN, Yongxia MEI, Beilei LIN, Shaoyang WANG, Qinghua ZHAI
Published: (2022-05-01)

Multimorbidity, medications, and their association with falls, physical activity, and cognitive functions in older adults: multicenter study in Sri Lanka
by: Warsha De Zoysa, et al.
Published: (2025-02-01)

Management of older adults with diabetes mellitus: Perspective from geriatric medicine
by: Hiroyuki Umegaki
Published: (2024-10-01)